West Pharmaceutical Services, Inc. Class Action Lawsuit - WST

The filed complaint alleges that West Pharmaceutical Services, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin HVP portfolio; (b) West’s SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to the Company’s profit margins due to operational inefficiencies; (c) these margin pressures created the risk of costly restructuring activities, including the Company’s exit from continuous glucose monitoring contracts with longstanding customers; and (d) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis.

In order to be eligible to join the WST class action lawsuit, you must have incurred a loss on shares of West Pharmaceutical Services, Inc. purchased during the class period listed above.

If you suffered a loss in West Pharmaceutical Services, Inc. during the relevant time frame or pursuant to the relevant offering(s), you have until July 7, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.